SOPHiA Lymphoma Solution
This comprehensive solution accurately covers 54 genes associated with B- and T-cell lymphomas such as diffuse large B-cell, follicular, mantle cell and Burkitt lymphoma. The application combines a capture-based target enrichment kit with the advanced analytical capabilities of the SOPHiA DDM™ platform, providing high-quality and reproducible data through a streamlined workflow from sample to report.
Streamline interpretation with the SOPHiA DDM™ intuitive variant filters, algorithm-supported variant classification with OncoPortal™ to obtain the latest scientific evidence on all the relevant variants
Confidentially asses complex variants associated with cancers of the lymphatic system
This comprehensive solution accurately covers 54 genes associated with B- and T-cell lymphomas such as diffuse large B-cell, follicular, mantle cell and Burkitt lymphoma. Through a streamlined, customizable, and scalable NGS-based workflow, SOPHiA Lymphoma Solution reduces turnaround time and improves the efficiency of assessing complex variants associated with lymphomas.
Dedicated features to ease variant interpretation
The SOPHiA DDM™ platform features intuitive variant filters and prioritization options to streamline the interpretation process and help you greatly reduce turnaround time.
- Virtual Panels to limit the interpretation to a subset of genes
- Cascading Filters to enable user-created custom filtering strategies for quicker identification of relevant variants
- OncoPortal™ to support decisions based on the Jax-CKB™, CAP, ASCO, AMP and other data sources
|Addressed Diseases||B- and T-cell lymphomas such as diffuse large B-cell, follicular, mantle cell, and Burkitt lymphomas|
|Genes||54 genes with complete coding sequences. Panel: ARID1A, B2M, BCL2, CCND3, CD58, CHD2, CDKN2A, CDKN2B, CIITA, CXCR4, EP300, FOXO1, GNA13, ID3, IRF4, KMT2A, KMT2D, MAL, MEF2B, MYC, MYD88, NFKBIE, PAX5, PIM1, POT1, PRDM1, PTPN11, REL, SOCS1, TNFAIP3, TNFRSF14, TP53, ATM, BCL6, BIRC, BRAF, BTK, CARD11, CCND1, CD79A, CD79B, CREBBP, EZH2, FBXW7, KRAS, NOTCH1, NOTCH2, NRAS), PLCG2, PTEN, SF3B1, STAT6, TCF3, XPO1|
|Key Biomarkers||CREBBP, EP300, EZH2, MEF2B, MYD88, MYC, BRAF|
|Starting Material||50 ng DNA|
|Target Region Size||118 Kb|
|Sample Type||FFPE, blood, and bone marrow|
|Library Preparation Time||1.5 days|
|Analysis Time From FASTQ File||From 4 hours|
Please fill out the form below to get in touch
SOPHiA DDM™ for Blood Cancers
Our future-proof end-to-end solutions allow detection and characterization of complex genomic variants associated with different blood cancers.
SOPHiA DDM™ for Solid Tumors
From targeted to comprehensive genomic profiling, our solutions support healthcare professionals in their journey to analyze solid tumors.
SOPHiA DDM™ for Hereditary Cancers
Our solutions help reduce time to confidently assess multiple types of challenging genetic variants that indicate predisposition to inherited cancers.